<DOC>
	<DOCNO>NCT00276445</DOCNO>
	<brief_summary>Intravenous- injection beta-1,3-glucan human know induce T helper type 1 response , oral uptake . It examine whether superfine disperse beta-1,3-glucan ( SDG ) contrive absorbed intestinal mucosa would alleviate allergic symptom per-oral ingestion</brief_summary>
	<brief_title>Alleviation Cedar Pollen Induced Allergic Symptoms Orally Taken Superfine Beta-1,3-Glucan</brief_title>
	<detailed_description>Beta-1,3-glucan make Japanese mushroom commercially available healthy foodstuff . Allergy patient orally administrate either SDG ( n=30 ) non-dispersed beta-1,3-glucan ( NDG , n=30 ) allergic symptom assess clinically , double-blind , placebo-controlled , randomize study</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Beta-1,3-glucan</mesh_term>
	<criteria>history seasonal allergic conjunctivitis without rhinitis spring ( Japanese cedar pollen season ) every year positive allergen specific IgE ( &gt; 30 IU/ml ) positive skin prick test result ( wheal diameter &gt; 3mm ) Japanese cedar , Orchard Grass pollen , house dustmite extract Patients undergone immunotherapy previous 5 year history immunological medically relevant disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2004</verification_date>
	<keyword>allergy</keyword>
	<keyword>Allergy conjunctivitis</keyword>
	<keyword>beta-1-3glucan</keyword>
	<keyword>Th1/Th2</keyword>
</DOC>